Suchergebnisse - "Gabay, Cem"

PubPharm (27)

1

Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2021

von Kessel, C. | Vollenberg, R. | Masjosthusmann, K. | +12

2

The role of the IL-1 system in pregnancy and the use of IL-1 system markers to identify women at risk for pregnancy complications†

enthalten in: Biology of reproduction | 2020

von Equils, O. | Kellogg, C. | McGregor, J. | +3

3

Serum calprotectin : a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

enthalten in: Arthritis research & therapy | 2020

von Jarlborg, M. | Courvoisier, D. | Lamacchia, C. | +7

4

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis research & therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

5

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis Research & Therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

6

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis Research & Therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

7

IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome

enthalten in: Rheumatology (Oxford, England) | 2020

von Yasin, S. | Fall, N. | Brown, R. | +6

8

Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

enthalten in: Advances in rheumatology (London, England) | 2019

von Tuckwell, K. | Gabay, C. | Sornasse, T. | +3

9

Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

enthalten in: Advances in rheumatology | 2019

von Tuckwell, K. | Gabay, C. | Sornasse, T. | +3

10

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

enthalten in: Annals of the rheumatic diseases | 2018

von Gabay, C. | Fautrel, B. | Rech, J. | +14

CommentIn: Ann Rheum Dis. 2018 Dec;77(12):1699-1701. - PMID 29860231